Severe Reversible Azotemia From Captopril Therapy
- 1 March 1983
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 143 (3), 437-441
- https://doi.org/10.1001/archinte.1983.00350030047009
Abstract
• We saw three cases of severe reversible azotemia secondary to captopril therapy in hypertension. All patients had extensive peripheral vascular disease involving the renal arteries, and two patients (patients 2 and 3) had high levels of peripheral plasma renin activity. The azotemia occurred approximately two weeks after exposure to captopril, and fever, a maculopapular pruritic cutaneous rash, and eosinophilia developed in two patients (patients 2 and 3). The cause of the azotemia in our patients is not clearly known, since renal biopsies were not performed. The most likely cause for the azotemia was volume contraction with reduction in the glomerular filtration rate, although a direct insult to the kidney could not be excluded. (Arch Intern Med 1983;143:437-441)Keywords
This publication has 6 references indexed in Scilit:
- Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.Circulation, 1980
- Reversible renal failure during treatment with captopril.BMJ, 1979
- TEMPORARY AGEUSIA RELATED TO CAPTOPRILThe Lancet, 1979
- Reversible renal failure during treatment with captopril.BMJ, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- THE DISAPPEARANCE OF BRADYKININ AND ELEDOISIN IN THE CIRCULATION AND VASCULAR BEDS OF THE CATBritish Journal of Pharmacology and Chemotherapy, 1967